Management of Acute Lymphoblastic Leukemia in Older Patients
- 30 April 2006
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 43 (2) , 126-133
- https://doi.org/10.1053/j.seminhematol.2006.01.007
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Subtype Adjusted Therapy Improves Outcome of Elderly Patients with Acute Lymphoblastic Leukemia (ALL).Blood, 2004
- Enrollment of Elderly Patients in Clinical Trials for Cancer Drug Registration: A 7-Year Experience by the US Food and Drug AdministrationJournal of Clinical Oncology, 2004
- Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experienceAnnals of Hematology, 2004
- Cytogenetics in acute leukemiaBlood Reviews, 2003
- Participation of Patients 65 Years of Age or Older in Cancer Clinical TrialsJournal of Clinical Oncology, 2003
- Acute lymphoblastic leukemia in the elderly: The Edouard Herriot hospital experienceAmerican Journal of Hematology, 2001
- Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic LeukemiaJournal of Clinical Oncology, 2000
- The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working PartiesLeukemia, 1998
- Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XABritish Journal of Haematology, 1997
- Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Francais de Cytogenetique Hematologique [published erratum appears in Blood 1996 Oct 1;88(7):2818]Blood, 1996